S. 259
Referred to CommitteeSafe and Affordable Drugs from Canada Act of 2021
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2/4/2021 • Senate
Summary
Safe and Affordable Drugs from Canada Act of 2021
This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.
Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.
An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.
The FDA shall publish a list of approved Canadian pharmacies on a website.
Introduced in Senate • 2/4/2021
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (13)
Party Breakdown
Sponsor
Cosponsors (12)
Bill Journey
Originated in the Senate
Introduced
February 4, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law